Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

SAS Innovation Theater: The Role of Augmented Clinical Trials in the Response to COVID-19 and Beyond

Session Chair(s)

Jim  Box, MBA, MS

Jim Box, MBA, MS

Principal Data Scientist

SAS, United States

The COVID-19 pandemic is accelerating adoption of new technology and advanced analytics to mitigate delays in clinical research. Virtual and hybrid trial designs are ideal for improving patient enrollment and retention by reducing or eliminating the need for site visits. Approaches like direct-to-patient drug supply, remote patient monitoring, telemedicine, modeling for missing data, and more integrated and personalized patient communication can keep clinical research moving forward despite slowdowns to traditional site-based research caused by stay-at-home orders and social distancing. In addition, augmented trial methodologies lead to increased trial outcomes, enable real-time decisions around safety and help prevent risks of supply shortage. Machine learning and AI, supported by the Internet of Medical Things, enable this innovation in trial design by keeping researchers connected to patients and their data.

Speaker(s)

Matt  Becker

Panelist

Matt Becker

SAS, United States

Life Science Strategic Advisor

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.